ShareValue scores for 000153.SHE: Valuation 70, Quality 36, Growth 32, Health 46.

000153.SHE
SZSE

Anhui Fengyuan Pharmaceutical Co Ltd

CN¥5.37(+0.94%)

Updated

Loading chart...
Sentiment

Pulse

Rating

Low

Trap Risk

P/E to median

Not enough data
Valuation
70
Fair Value

vs Shenzhen-listed Healthcare stocks

Price vs Value
Quality
36
Weak
Business Strength
Growth
32
Weak
Revenue & Earnings
Health
46
Moderate
Financial Stability
Price trend
50
Neutral
Separate from the four scores

Company Details

About

Anhui Fengyuan Pharmaceutical Co., Ltd. researches and develops, produces, and sells medicines in China. The company offers biopharmaceuticals, chemical pharmaceuticals, traditional Chinese medicine preparations, processed Chinese medicinal herbs, and raw materials. It also provides antipyretics and analgesics, gynecological and pediatric drugs, nervous system drugs, cardiovascular system drugs, urinary system drugs, nutritional drugs, and antibiotics. Anhui Fengyuan Pharmaceutical Co., Ltd. was founded in 1997 and is based in Hefei, China.

Score Analysis

AI Investment Thesis

Data as of:Nov 11, 2026

By using ShareValue.ai you agree to our Terms and Privacy Policy. Educational platform, not investment advice.